Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-17

Clinical Trial Update: A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating absorption, metabolism, and excretion of Asacol in children and adolescents with Ulcerative Colitis; the trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asacol (mesalamine)

Snippet

Sponsor: Warner Chilcott | Conditions: Ulcerative Colitis | Phase 1 | Status: TERMINATED